Differential impact of clinicopathological risk factors within the 2 largest ProMisE molecular subgroups of endometrial carcinoma.
<h4>Objective</h4>To assess whether the prognostic impact of conventional risk factors and ancillary biomarkers differs across the 2 largest ProMisE molecular subgroups of endometrial carcinoma (EC).<h4>Methods</h4>Direct sequencing of POLE exonuclease domain hot spots and im...
Guardado en:
Autores principales: | Annukka Pasanen, Mikko Loukovaara, Terhi Ahvenainen, Pia Vahteristo, Ralf Bützow |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d71ddb2b73cd4825865a760f909702f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas
por: Hanna-Riikka Heinonen, et al.
Publicado: (2017) -
Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma
por: Iason Psilopatis, et al.
Publicado: (2021) -
Mis lecturas /
por: Giussani, Luigi
Publicado: (2005) -
On anti-fuzzy subgroup
por: Gayen Sudipta, et al.
Publicado: (2021) -
MEASURES OF FUZZY SUBGROUPS
por: Rui Shi,Shu
Publicado: (2010)